United States - Ohio Prevalence of Current and Past COVID-19 in Adults July 2020
Prevalence of Current and Past COVID-19 in Ohio Adults
Survey:
Epi surveillance - Individual
Blood tests
Dataset Records for Blood tests
Displaying 101 - 150 of 1806
SARS-CoV-2 Seroprevalence in 12 Cities of India from July-December 2020. Preprint
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of anti-SARS-CoV-2 antibodies in Iquitos, Loreto, Peru. Preprint
GHDx Entry last modified on: Jun 18, 2021
Serum-epidemiological Survey of SARS-CoV-2, City of Pemba (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Pemba (InCOVID 2020) - Resultados Preliminares -
Norway SARS-CoV-2 Seroprevalence Residual Sera Follow-up Survey July-September 2020
Seroprevalence of SARS-CoV-2 in the Norwegian population measured in residual sera collected in late summer 2020
Survey:
Epi surveillance - Individual
CDC COVID Data Tracker Nationwide Blood Donor Seroprevalence Survey 2021-2022
Survey:
Epi surveillance - Subnationally representative
Singapore National Population Health Survey 2020-2021
Survey:
Cross-sectional - Exam - Household - Interview - Nationally representative
The Burden of COVID-19 Infection in a Rural Tamil Nadu Community. Preprint
GHDx Entry last modified on: Mar 14, 2022
Israel - Press Releases Results of the National Serological Survey for Novel Coronavirus
GHDx Entry last modified on: May 12, 2022
Prevalence of SARS-CoV-2 in six districts in Zambia in July, 2020: a cross-sectional cluster sample survey
GHDx Entry last modified on: Feb 10, 2022
Serial SARS-CoV-2 Seropravelence Studies in Delhi July-August 2020: Indications of Pre-existing Cross-reactive Antibodies and Implications for Disease Progression
GHDx Entry last modified on: Mar 14, 2022
Assam’s First Sero-survey Gets Underway, Here’s Everything You Need To Know About It
GHDx Entry last modified on: Aug 1, 2022
SARS-CoV-2 seroprevalence in Germany - a population based sequential study in five regions. Preprint
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of anti-SARS-CoV-2 IgG at the epidemic peak in French Guiana. Preprint
GHDx Entry last modified on: Mar 14, 2022
Anti-SARS-CoV-2 IgG seroprevalence study among blood donors in the Republic of Srpska: a 30-day survey
Studija seroprevalencije anti-SARS-CoV-2 IgG kod davalaca krvi u Republici Srpskoj: 30-dnevno ispitivanje
[Minsa publishes technical data of the study that reveals that 25.3% of Lima and Callao acquired COVID-19]
Minsa divulga ficha técnica del estudio que revela que el 25.3% de Lima y Callao adquirió el COVID-19
Survey:
Epi surveillance
Colombia - Bogota Sabana University Clinic Long Covid Cohort Study 2020-2022
Survey:
Emergency - Exam - Health facility - Individual - Inpatient - Interview - Longitudinal
One in Three Exposed to Covid Virus, Reveals Second Chennai Sero Survey
GHDx Entry last modified on: May 12, 2022
Variation in SARS-CoV-2 seroprevalence in school-children across districts, schools and classes. Preprint
GHDx Entry last modified on: Mar 14, 2022
Sero-prevalence of SARS-CoV-2 Antibody Among Adults in the General Population in Diredawa, Ethiopia. Preprint
GHDx Entry last modified on: Sep 13, 2022
Prevalence of SARS-CoV-2 in Karnataka, India
GHDx Entry last modified on: Mar 14, 2022
Declining prevalence of antibody positivity to SARS-CoV-2: a community study of 365,000 adults. Preprint
GHDx Entry last modified on: May 12, 2022
Ireland Study to Investigate COVID-19 Infection in People Living in Ireland (SCOPI) 2020
Survey:
Epi surveillance
SARS-CoV-2 seroprevalence and characteristics of post-infection immunity in a general population cohort study in Catalonia, Spain. Preprint
GHDx Entry last modified on: May 12, 2022
Presence of antibodies against SARS-CoV-2 in the district area Rinkeby-Kista, Stockholm, 22–24 June 2020
Förekomsten av antikroppar mot SARS-CoV-2 i stadsdelsområdet Rinkeby-Kista, Stockholm, 22–24 juni 2020
Survey:
Community - Cross-sectional - Exam - Urban only
Dramatic Rise of Seroprevalence Rates of SARS-CoV-2 Antibodies among Healthy Blood Donors: The evolution of a Pandemic. Preprint
GHDx Entry last modified on: Oct 6, 2022
SARS-CoV-2 antibody prevalence in England following the first peak of the pandemic
GHDx Entry last modified on: Dec 11, 2023
Montenegro Institute of Public Health COVID-19 Dashboard June 2020
GHDx Entry last modified on: May 12, 2022
SARS-CoV-2 antibody prevalence and symptoms in a local Austrian population. Preprint
GHDx Entry last modified on: Mar 14, 2022
Afghanistan National COVID-19 Prevalence and Related Deaths Survey 2020
National Survey of Prevalence of COVID-19 and its Related Deaths in Afghanistan
Survey:
Cross-sectional - Individual - Interview - Nationally representative - Subnationally representative - Urban-rural representative
Seroprevalence of SARS-CoV-2 antibodies in an entirely PCR-sampled and quarantined community after a COVID-19 outbreak - the CoNAN study. Preprint
GHDx Entry last modified on: Mar 14, 2022
Fernando de Noronha: how an island controlled the community transmission of COVID-19 in Brazil. Preprint
GHDx Entry last modified on: Mar 14, 2022
Anti-SARS-CoV-2 IgG antibodies in adolescent students and their teachers in Saxony, Germany (SchoolCoviDD19): very low seropraevalence and transmission rates. Preprint
GHDx Entry last modified on: Mar 14, 2022
Phase 2 of Sero Survey Begins in Latehar, Simdega, Pakur
GHDx Entry last modified on: Feb 10, 2022
Increase in SARS-CoV-2 seroprevalence in healthy blood donors after the second wave of COVID-19 pandemic in South-Eastern Italy: evidence for asymptomatic young individuals as potential virus spreaders. Preprint
GHDx Entry last modified on: Mar 14, 2022
India - Kerala COVID 19 Sero Surveillance Report August - September 2021
COVID 19 Sero Surveillance Report
Survey:
Cross-sectional - Epi surveillance
Seroprevalence of SARS-CoV-2 in the West Bank region of Palestine: a cross-sectional seroepidemiological study
GHDx Entry last modified on: Mar 14, 2022
COVID-19: around 35 000 people have been tested
GHDx Entry last modified on: Feb 10, 2022
Seroprevalence of SARS-CoV-2 IgM and IgG antibodies in an asymptomatic population in Sergipe, Brazil
GHDx Entry last modified on: Jun 17, 2021
The seroprevalence of SARS-CoV-2 IgG antibodies among asymptomatic blood donors in Saudi Arabia
GHDx Entry last modified on: Jun 17, 2021
Canada - Quebec COVID-19 First Wave Blood Donor Seroprevalence Study 2020
Étude De Séroprévalence Des Anti-Sras-Cov-2 Chez Les Donneurs De Sang D’héma-Québec, Vers La Fin De La Première Vague De Covid-19
Survey:
Epi surveillance
Positive Rate of Serology and RT-PCR for COVID-19 between Community Residents and Healthcare Workers in Wuhan, China
GHDx Entry last modified on: Mar 14, 2022
SARS CoV-2 Serosurvey in Addis Ababa, Ethiopia. Preprint
GHDx Entry last modified on: Mar 14, 2022
Scotland Enhanced Surveillance of Covid-19 Dashboard 2020-2022
Enhanced Surveillance of Covid-19 in Scotland (Population-based seroprevalence)
Epi surveillance:
Epi surveillance
Prevalence of SARS-CoV-2 Antibodies from a one-year National Serosurveillance of Kenyan Blood Transfusion Donors. Preprint
GHDx Entry last modified on: Mar 14, 2022
Spain - National Study of Sero-epidemiology of Infection by Sars-Cov-2 2020
Estudio Nacional de Sero-epidemiología de la Infección por Sars-Cov-2 en España
Survey:
Exam - Household - Interview - Longitudinal
Seroprevalence of Specific Antibodies against SARS-CoV-2 from Hotspot Communities in the Dominican Republic
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence and correlates of SARS-CoV-2 neutralizing antibodies: Results from a population-based study in Bonn, Germany. Preprint
GHDx Entry last modified on: Mar 14, 2022
CDC COVID Data Tracker Commercial Laboratory Seroprevalence Survey Data 2020-2022
Survey:
Epi surveillance - Individual - Subnationally representative
Subscribe